Serum Leptin Might Be Causally Correlated to Invasive Ductal Breast Carcinoma
| Autor: | Emad M. Nafie, Shaikh Mizan, Nasser Muhammad Amjad, Norra Harun, Saad M. Al-Shibli, Muna Khaleel Dheyab Al-Kubaisi |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry Leptin digestive oral and skin physiology White adipose tissue medicine.disease_cause Hormone secreted medicine.disease Obesity Breast cancer Internal medicine Serum leptin Medicine Invasive Ductal Breast Carcinoma skin and connective tissue diseases business Carcinogenesis hormones hormone substitutes and hormone antagonists |
| Zdroj: | Journal of Clinical & Experimental Oncology. |
| ISSN: | 2324-9110 |
| DOI: | 10.4172/2324-9110.1000211 |
| Popis: | Introduction: Leptin, the hormone secreted from white adipose tissue is suspected of being a causative factor in tumorigenesis in various tissues. Thus it might be a link between obesity and breast cancer. Objectives: In this project we tried to study causative association of obesity and serum leptin with invasive ductal breast cancer (IDC) in a sample of Malaysian population. Methods: We measured various obesity parameters, and estimated serum leptin levels in a group of healthy control and IDC patients. After confirming diagnosis by standard histopathological methods, serum leptin levels were estimated using ELISA. Both the pre-and postoperative leptin levels were measured with the Patient group. Results: The difference between the serum leptin levels of the Control and the Patient group were highly significant with a P value of 0.05). Conclusion: Since high serum leptin in IDC patients persists unabated in the post-operative state, we infer that the source of leptin in these cases cannot be the breast cancer tissue itself and leptin cannot be a marker for breast cancer. Highly significant association between serum leptin and IDC patients suggests that leptin in serum might play a causative role in the tumorigenesis of breast cancer, and it might be an important connection between obesity and breast cancer. Therefore, leptin signal transduction pathway might be a prospective therapeutic target in the treatment and prevention of IDC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|